Martin Abild Stengaard Meyer

Medicine & Life Sciences

1. Out-of-Hospital Cardiac Arrest 100%
2. Thrombelastography 68%
3. Heart Arrest 52%
4. Coma 40%
5. tocilizumab 34%
6. Post-Cardiac Arrest Syndrome 32%
7. Interleukin-6 Receptors 26%
8. Wounds and Injuries 26%
9. Phosphopyruvate Hydratase 24%
10. Endotoxemia 24%
11. Biomarkers 24%
12. Placebos 20%
13. Survivors 17%
14. Brain Injuries 17%
15. Hemostatics 17%
16. Intermediate Filaments 17%
17. Glycocalyx 17%
18. Sepsis 16%
19. Induced Hypothermia 16%
20. Fibrinogen 15%
21. Syndecan-1 15%
22. antineoplaston A10 15%
23. Randomized Controlled Trials 15%
24. Iloprost 14%
25. Fibrinolysis 14%
26. Lipocalin-2 13%
27. Dabigatran 13%
28. Protein C 12%
29. Interleukin-6 12%
30. Thrombomodulin 12%
31. Inflammation 12%
32. Mortality 11%
33. Epoprostenol 11%
34. Metabolome 11%
35. Light 11%
36. ST Elevation Myocardial Infarction 11%
37. Antibodies 11%
38. Mental Status and Dementia Tests 11%
39. Hyperemia 11%
40. Catecholamines 10%
41. Hemolysis 10%
42. Blood Pressure 10%
43. Traumatic Brain Injury 10%
44. Acute Kidney Injury 9%
45. Cause of Death 9%
46. Multicenter Studies 8%
47. MicroRNAs 8%
48. Magnetic Resonance Spectroscopy 8%
49. Blood Platelets 8%
50. Confidence Intervals 8%